Home Page | Lorbrena® (lorlatinib) Official Patient Site | Safety Info
Learn more about the risks and benefits of LORBRENA® (lorlatinib), an Rx treatment option. FOR LIVE SUPPORT, CALL 1-877-744-5675 REGISTER FOR A CO-PAY SAVINGS CARD
about-lorbrena
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
About ALK+ NSCLC | Lorbrena® (lorlatinib) Patient Site | Safety Info
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
LORBRENA® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
Taking Lorbrena | Lorbrena® (lorlatinib) Patient Site | Safety Info
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has …
LORBRENA ® (lorlatinib) es un medicamento de venta con receta que se utiliza para tratar a adultos con cáncer de pulmón no microcítico (CPNM) causado por un gen anómalo de la …
and Patient Information or visit LORBRENA.com. STARTING TREATMENT WITH LORBRENA® (lorlatinib) Guide to common side effects LORBRENA is a prescription medicine that is used to …
Care Champion Support | Lorbrena® (lorlatinib) Patient Site
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has